nivolumab,ipilimumab
bms
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
when a waterfall becomes a lake - immunotherapy in 120 mismatch repair deficient crc cases. 
Medical oncologist and cancer scientist in Oxford. Enthusiastic about mRNA, cancer prevention, ovarian cancer research and survivorship. Views are my own.